Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this Warning Letter issued to Spartan Chemical Company, Inc. on December 15, 2021, concerns drug products under FDA jurisdiction. Without access to the full letter text or subject line, the specific nature of the violations cannot be detailed, though the warning indicates significant regulatory compliance concerns warranting formal FDA enforcement action. The letter falls under FDA's drug product oversight authority, though the specific issuing office is not identified in the available metadata.